EC Number   |
Title |
Organism |
|---|
   1.3.1.1 | 5-Fluorouracil toxicity-attributable IVS14+1G>A mutation of the dihydropyrimidine dehydrogenase gene in Polish colorectal cancer patients |
Homo sapiens |
| 1.3.1.1 | Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy |
Homo sapiens |
| 1.3.1.1 | Cloning, expression, purification, characterization, crystallization and x-ray diffraction of bifunctional pyrimidine deaminase/reductase from Shigella flexneri 2a |
Shigella flexneri |
| 1.3.1.1 | Cloning, expression, purification, characterization, crystallization and x-ray diffraction of bifunctional pyrimidine deaminase/reductase from Shigella flexneri 2a |
Shigella flexneri 2a |
| 1.3.1.1 | Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity |
Homo sapiens |
| 1.3.1.1 | Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer |
Homo sapiens |
| 1.3.1.1 | Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer |
Homo sapiens |
| 1.3.1.1 | Escherichia coli dihydropyrimidine dehydrogenase is a novel NAD-dependent heterotetramer essential for the production of 5,6-dihydrouracil |
Escherichia coli |
| 1.3.1.1 | Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in adenoid cystic carcinoma of the head and neck: Correlation with clinical outcome |
Homo sapiens |
| 1.3.1.1 | Identification of dihydropyrimidine dehydrogenase as a virulence factor essential for the survival of Entamoeba histolytica in glucose-poor environments |
Entamoeba histolytica |
